Richard D Kim

5PUBLICATIONS
27CO-AUTHORS
Liquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2024
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.

Alison J Davis, Natasja Brooijmans, Jason D Brubaker

|Oct 03, 2019
Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.

Megan A Hatlen, Oleg Schmidt-Kittler, Cori Ann Sherwin

|Apr 17, 2018
Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.

Vivek Subbiah, Justin F Gainor, Rami Rahal

|Nov 03, 2017
A precision therapy against cancers driven by KIT/PDGFRA mutations.

Erica K Evans, Alexandra K Gardino, Joseph L Kim

Pageof 1